ADVICENNE (PROM.) EO-20
Healthcare · EUR · F
Price
€0.814
Cap
€18.53M
Earnings
—
30d Trend
-38.0%
97% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 41×Macro 0.99 (−1%)=41
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate ADVICENNE (PROM.) EO-20 at 41/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 66/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
-31.0%
3 MONTHS
-56.8%
12 MONTHS
-51.2%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Quality (66) and Technical (45) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 97%. I classify this as a speculative position — elevated volatility at 97% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.